In 2025, the Omega-3 Concentrates market was valued at USD 2.91 billion. Based on Future Market Insights' analysis, demand for Omega-3 Concentrates is estimated to grow to USD 3.31 billion in 2026 and USD 6.33 billion by 2036. FMI projects a CAGR of 6.7% during the forecast period.
The absolute dollar expansion from 2026 to 2036 amounts to approximately USD 3.02 billion. Growth is driven by the dietary supplement sector's expansion of omega-3 product lines targeting cardiovascular health, cognitive function, and inflammatory condition management, and by the infant formula sector's mandatory or recommended DHA inclusion requirements under national regulatory frameworks and Codex Alimentarius guidelines. Growth is moderated by raw material supply constraints linked to global fishmeal and fish oil production limits set by the International Fishmeal and Fish Oil Organisation, sustainability certification requirements from the Marine Stewardship Council, and the cost premium of algal and krill-derived omega-3 concentrates relative to conventional fish oil.
As per FMI, rising consumer adoption of omega-3 dietary supplements for cardiovascular, cognitive, and anti-inflammatory health positioning, combined with mandatory and recommended DHA inclusion in infant formula across regulated markets and growing functional food fortification procurement, creates multi-channel demand growth across dietary supplement, pharmaceutical, and food manufacturing application segments. India leads country-level growth at 5.9% CAGR, driven by expanding dietary supplement retail market penetration, growing awareness of omega-3 fatty acids' cardiovascular and cognitive health benefits among urban consumers, and domestic nutraceutical manufacturer procurement of fish oil concentrates for supplement encapsulation and functional food fortification. China follows at 5.5%, with DSM and ADM supplying omega-3 concentrates to infant formula manufacturers required to meet China's GB 10765-2021 standard for infant formula which specifies DHA content requirements, and to supplement manufacturers serving the large urban health supplement retail market
. Japan advances at 5.3%, with the aging population driving cardiovascular and cognitive health supplement procurement, and KD Pharma Group and Nordic Naturals supplying high-purity triglyceride-form omega-3 concentrates to pharmaceutical and nutraceutical manufacturers meeting Japanese Food with Function Claims notification requirements. The United States expands at 4.9%, with BASF SE, Corbion, and Nordic Naturals supplying fish and algal omega-3 concentrates to dietary supplement manufacturers and functional food producers, with AlaskOmega supplying MSC-certified Alaskan pollock-derived concentrates to the premium supplement segment. Australia advances at 4.6%, with Australian Omega Oils Pty. Ltd. supplying fish oil concentrates from sustainably certified Australian fisheries to domestic supplement and functional food manufacturers. For full country-level data and segment forecasts, refer to FMI's Omega-3 Concentrates Market report.
| Metric | Details |
|---|---|
| Industry Size (2026) | USD 3.31 billion |
| Industry Value (2036) | USD 6.33 billion |
| CAGR (2026 to 2036) | 6.7% |
| Source | Future Market Insights (FMI) |
Omega-3 Concentrates are purified and concentrated preparations of long-chain polyunsaturated fatty acids, principally eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), derived from marine sources including fish oil, krill oil, calamari oil, and algal oil through molecular distillation, enzymatic processing, or supercritical fluid extraction. They are supplied in triglyceride, ethyl ester, and phospholipid molecular forms across oil and powder delivery formats for use in dietary supplements, pharmaceuticals, infant formula, functional food and beverage fortification, nutraceuticals, personal care, and pet food applications.
The report covers global and regional market sizes for omega-3 concentrates across all form, source, molecular type, concentration, and end use categories, forecast data from 2026 to 2036, and country-level CAGR analysis for China, Japan, India, USA, and Australia, with additional regional coverage across more than 40 countries.
The scope excludes non-concentrated fish oil products with EPA and DHA content below 30% combined, flaxseed oil and chia seed oil supplying short-chain alpha-linolenic acid without EPA and DHA concentration, and omega-3 finished consumer products such as dietary supplement capsules and fortified food products where the omega-3 concentrate is formulated into a consumer-ready dosage form.
Future Market Insights analysis of the Omega-3 Concentrates market shows that demand is structured around specific procurement requirements across commercial, industrial, and regulated product categories. FMI analysts observe that growth performance varies across application and regional segments, with premium and specialty demand tiers delivering above-average revenue per unit relative to standard commodity supply.
FMI is of the opinion that the structural dynamic in this market reflects the interplay between production cost constraints and downstream buyer quality certification requirements. Suppliers able to demonstrate supply chain traceability, batch consistency, and regulatory compliance are positioned to secure disproportionate share of the premium procurement tier across all major geographic markets.
Omega-3 Fortification in Infant Formula is Gaining Momentum
Growing awareness of DHA's vital role in infant brain and visual development is considerably driving the inclusion of omega-3 concentrates in infant formula. DHA, a key omega-3 fatty acid, is essential for proper neurological and visual functioning in infants. Parents and healthcare specialist are progressively recognizing its importance, which is leading to a higher demand for fortified infant formulas.
Due to which, manufacturers are producing products with enhanced omega-3 concentrates to meet this growing demand, and ensuring infants receive optimal nutrition for healthy development during the crucial early stages of life.
Expanding Use of Omega-3 Concentrates in Personal Care and Cosmetics
The use of omega-3 concentrates in personal care and cosmetic products is expanding due to their proven skin health and anti-inflammatory properties. Omega-3 fatty acids help maintain skin hydration, improve elasticity, and reduce signs of aging by tackling inflammation and promoting cell membrane health.
As consumers become more health-conscious and are seeking natural ingredients, the demand for skincare and cosmetic products enriched with omega-3s is growing. This encourages manufacturers to innovate and include these beneficial concentrates in a wider range of beauty and personal care products.
Rise of Algae-Based Omega-3s: Meeting Sustainability Demands
There is a distinct shift towards sustainably sourced omega-3 fatty acids, particularly from algae-based products, driven by increasing environmental awareness among consumers. Algae-based omega-3 sources are considered as more eco-friendly compared to traditional fish-derived sources, which helps reduce concerns over marine ecosystem depletion.
This drift reflects a broader consumer preference for products that minimize environmental impact and promote sustainable practices. As awareness grows about the benefits of algae-based omega-3s, such as reduced environmental footprint and potential purity advantages, more consumers are opting for these sustainable alternatives for their dietary supplements and functional foods.
The rising popularity of dietary supplements as a means to enhance overall health and wellness has been a major stimulant for the growth of the omega-3 concentrate market.
Consumers are increasingly switching to supplements to complement their diets and address specific health concerns, including cardiovascular health, cognitive function, and inflammation reduction, domains where omega-3 fatty acids are well known to provide major benefits.
This shift is driven by growing health consciousness and the desire for preventive healthcare measures, pushing manufacturers to innovate and expand their offerings of omega-3 concentrates in various forms to meet the increasing demand in the supplement market.
Increasing awareness of pet health and nutrition is prompting the inlusion of omega-3 concentrates into pet food formulations. Omega-3 fatty acids, such as DHA and EPA, offer benefits for pets similar to those for humans, including support for joint health, coat condition, and overall immune system function.
As pet owners are searching to provide optimal nutrition for their animals, omega-3 enrichment in pet foods is becoming a essential attribute in meeting these health-conscious demands.
Tier 1 companies comprise industry leaders with market revenue of above USD 50 million capturing significant sales domain share of 45% to 55% in the global sphere. These business leaders are characterized by high production capacity and a wide product portfolio.
These trade leaders are distinguished by their extensive expertise in manufacturing and reconditioning across multiple packaging formats and a broad geographical reach, underpinned by a robust consumer base. Prominent companies within tier 1 include BASF SE, Nordic Naturals, DSM, ADM, and Corbion
Tier 2 companies include mid-size players with revenue of USD 10 to 50 million having presence in specific regions and highly influencing the local retail space. These are characterized by a strong presence overseas and strong consumer base knowledge.
These industry players have good technology and ensure regulatory compliance but may not have advanced technology and wide global reach. Prominent companies in tier 2 include Epax, GC Rieber (VivoMega), AlaskOmega, Norwegian Fish Oil, Golden Omega, KD Pharma Group, Orkla Health, and Olvea Omega Solutions
Tier 3 includes the majority of small-scale companies operating at the local presence and serving niche demand space having revenue below USD 10 million. These companies are notably oriented towards fulfilling local marketplace demands and are consequently classified within the tier 3 share segment.
They are small-scale players and have limited geographical reach. Tier 3, within this context, is recognized as an unorganized field, denoting a sector characterized by a lack of extensive structure and formalization when compared to organized competitors.
The table below highlights revenue from product sales in key countries. The China and Japan are predicted to remain top consumers, with estimated trade valuations of USD 5.9 million and USD 598.9 million, respectively, by 2036.
.webp "Top Country Growth Comparison Omega 3 Concentrates Market Cagr (2026 2036)")
| Countries | CAGR 2025 to 2035 |
|---|---|
| China | 5.5% |
| Japan | 5.3% |
| India | 5.9% |
| USA | 4.9% |
| Australia | 4.6% |
The demand space for Omega- 3 Concentrates in the Japan is projected to exhibit a CAGR of 5.3% during the assessment period. By 2036, revenue from the sales of Omega- 3 Concentrates in the country is expected to reach USD 598.9 Million.
Japan's aging population is one of the world's most prominent, has increased the requirement for health supplements aimed at reducing age-related issues. Omega-3 fatty acids, popular for their anti-inflammatory properties and contributions to heart and brain health, are especially appealing to older adults pursuing to maintain cognitive sharpness and cardiovascular well-being.
This demographics’ amplified health consciousness and proactive approach to aging, linked with widespread scientific endorsement of omega-3 benefits, drive strong market interest in Japan. As a result, products enriched with omega-3 concentrates are consequently featured in the country's healthcare and wellness strategies aimed at supporting longevity and quality of life.
Omega- 3 Concentrates demand in India is calculated to rise at a value CAGR of 5.9% during the forecast period (2025 to 2035). By 2036, India is expected to account for 32.6% of Omega- 3 Concentrates sales in East Asia.
Most of the Indians experience dietary deficiencies in essential nutrients like omega-3 fatty acids, determined by traditional diets that often lack adequate fish consumption. This deficiency has boosted interest in omega-3 supplements as a convenient solution to bridge nutritional gaps and support overall health.
Simultaneously, the rising frequency of lifestyle-related diseases such as cardiovascular conditions, diabetes, and cognitive decline has pointed out the importance of preventive healthcare strategies.
Omega-3 supplements are incrementally getting recognized as a proactive measure to reduce these health risks, promoting their adoption among individuals looking to maintain or improve their long-term health issues in India's evolving healthcare environment.
Consumption of Omega- 3 Concentrates in USA is projected to increase at a value CAGR of 4.9% over the next ten years. By 2036, the business size is forecasted to reach USD 164.3 Million, with China expected to account for a domain share of 78.3% in East Asia.
Omega-3s has gained popularity among athletes and fitness enthusiasts in the USA because of their perceived benefits for joint health, reducing inflammation, and enhancing overall physical performance. These fatty acids are considered to support recovery and reduce exercise-induced muscle soreness, which makes them a preferred supplement in the fitness community.
While, ongoing product innovation has further boosted their appeal. Advances such as higher concentrations and improved food attributes in omega-3 supplements cater to consumer preferences for effectiveness and palatability, further driving greater acceptance and integration of these products into daily health routines among active individuals in the country.
| Segment | Fish (Source) |
|---|---|
| Value Share (2026) | 41.6% |
Sales of fish sourced Omega- 3 Concentrates are projected to register a CAGR of 5.7% from 2025 to 2035. Fish-sourced omega-3s, especially in the form of triglycerides, are often more bioavailable and easily absorbed by the body compared to plant-based or other sources, which ensures more efficient utilization of these essential fatty acids.
Extensive research and clinical studies have shown the health benefits of fish-derived omega-3 fatty acids, specifically EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid).
These benefits include improved heart health, cognitive function, and anti-inflammatory properties, making them highly sought after. Furthermore, fish oil concentrates typically contain higher levels of EPA and DHA compared to plant-based omega-3 sources. This higher concentration means that consumers can achieve therapeutic benefits with smaller doses, enhancing the appeal and effectiveness of fish-sourced omega-3 supplements.
| Segment | Food & Beverages (End Use) |
|---|---|
| Value Share (2026) | 38.2% |
The Food & Beverages segment is anticipated to advance at 6.2% CAGR during the projection period.
Food and beverage companies are determined to differentiate their products in a competitive marketplace by adding omega-3 concentrates. This addition allows them to trade their offerings as health-enhancing, appealing to the growing segment of health-conscious consumers pursuing functional benefits from their food and beverages.
Moreover, many consumers suffer from nutritional deficiencies, particularly in omega-3 fatty acids, due to insufficient dietary intake of fish and other sources. Fortifying foods and beverages with omega-3s provides a convenient solution for increasing omega-3 intake without requiring crucial change in eating habits.
This fortification benefits consumers to meet their nutritional needs easily, supporting overall health and wellness, and further driving the demand for omega-3-enriched products in the market.
The Omega- 3 Concentrates market encompasses a diverse and dynamic competitive landscape. Leading Omega- 3 Concentrates manufacturing companies are focusing on research and development, sustainable sourcing, and new formulations. They are also emphasizing environment-friendly practices and product certifications to satisfy the increasing demand for natural and sustainable ingredients.
For instance
| Metric | Value |
|---|---|
| Quantitative Units | USD 3.31 billion to USD 6.33 billion, at a CAGR of 6.7% |
| Market Definition | Omega-3 Concentrates are purified and concentrated preparations of long-chain polyunsaturated fatty acids, principally eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), derived from marine sources including fish oil, krill oil, calamari oil, and algal oil through molecular distillation, enzymatic processing, or supercritical fluid extraction. They are supplied in triglyceride, ethyl ester, and phospholipid molecular forms across oil and powder delivery formats for use in dietary supplements, pharmaceuticals, infant formula, functional food and beverage fortification, nutraceuticals, personal care, and pet food applications. |
| Form Segmentation | Oil, Powder |
| Source Segmentation | Fish, Krill, Calamari, Algae, Others |
| Type Segmentation | Triglyceride, Ethyl Ester, Phospholipids |
| Concentration Segmentation | High EPA, High DHA, Balanced EPA to DHA |
| End Use Segmentation | Dietary Supplements, Food and Beverages, Pharmaceuticals, Nutraceuticals, Infant Formula, Personal Care and Cosmetics, Pet Food |
| Packaging Segmentation | Drums, Totes |
| Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa |
| Countries Covered | China, Japan, India, USA, Australia, and 40 plus countries |
| Forecast Period | 2026 to 2036 |
| Key Companies Profiled | Australian Omega Oils Pty. Ltd., BASF SE, Epax, GC Rieber (VivoMega), AlaskOmega, Norwegian Fish Oil, Nordic Naturals, DSM, Golden Omega, ADM, KD Pharma Group, Corbion, Orkla Health, Olvea, Omega Solutions |
| Approach | Hybrid bottom-up and top-down forecasting model, cross-validated against primary interview findings and public benchmark data |
As per form, the market has been categorized into powder and oil
This segment is further categorized into krill, fish, calamari, algae, and others
As per type, the market has been categorized into triglyceride (TG), ethyl ester (EE), and phospholipids (PL)
This segment is further categorized into High DHA, High EPA, and Balanced EPA: DHA
As per end use, the market has been categorized into food and beverages, dietary supplements, pharmaceuticals, nutraceuticals, infant formula, personal care and cosmetics, and pet food
This segment is further categorized into drums and totes
Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.
This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.
How large is the demand for Omega-3 Concentrates in the global market in 2026?
Demand for Omega-3 Concentrates in the global market is estimated to be valued at USD 3.31 billion in 2026.
What will the market size of the Omega-3 Concentrates market be by 2036?
The Omega-3 Concentrates market is projected to reach USD 6.33 billion by 2036.
What is the expected CAGR for the Omega-3 Concentrates market between 2026 and 2036?
Demand for Omega-3 Concentrates is expected to grow at a CAGR of 6.7% between 2026 and 2036.
Which form leads the Omega-3 Concentrates market in 2026?
Oil form accounts for approximately 63.4% share in 2026, reflecting the dominant procurement of omega-3 concentrates in bulk oil format by dietary supplement encapsulation manufacturers, pharmaceutical producers, and infant formula manufacturers who incorporate liquid omega-3 oil directly into their manufacturing processes.
Which source leads the Omega-3 Concentrates market in 2026?
Fish source accounts for approximately 54.8% share in 2026, supported by the established supply chain infrastructure for fish oil concentration from species including anchovy, sardine, mackerel, and Alaskan pollock, and the extensive clinical evidence base for fish-derived EPA and DHA health benefits across cardiovascular, cognitive, and inflammatory condition management.
Which end use leads the Omega-3 Concentrates market in 2026?
Dietary Supplements holds approximately 41.6% end use share in 2026, driven by consumer adoption of omega-3 supplement products for cardiovascular health, cognitive function, and inflammatory health management across North America, Europe, Japan, and emerging Asian markets.
What regulatory requirement drives DHA omega-3 procurement in China?
China's GB 10765-2021 food safety national standard for infant formula specifies minimum DHA content requirements of 0.2% of total fatty acids, creating mandatory procurement demand for high-purity DHA omega-3 concentrates from infant formula manufacturers in China, with DSM and Corbion among the primary suppliers of compliant DHA concentrates to this regulated application.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Omega-3 Concentrates Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
